Respiratory syncytial virus vaccine - Mymetics Corporation
Latest Information Update: 10 Apr 2025
At a glance
- Originator Mymetics Corporation
- Class Respiratory syncytial virus vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Discontinued Respiratory syncytial virus infections
Most Recent Events
- 31 Mar 2024 Discontinued - Preclinical for Respiratory syncytial virus infections (Prevention) in Netherlands (Parenteral)
- 31 Dec 2016 Suspended - Preclinical for Respiratory syncytial virus infections (Prevention) in Netherlands (Parenteral) (9190661; 3478852)
- 25 Jul 2016 Respiratory Syncytial Virus is no longer licensed to RSV Corporation